L-selectin binding activity for its ligand expressed by vascular endothelium is rapidly and transiently increased after leukocyte activation. To identify mechanisms for upregulation and assess how this influences leukocyte/endothelial cell interactions, cell-surface dimers of L-selectin were induced using the coumermycin–GyrB dimerization strategy for cross-linking L-selectin cytoplasmic domains in L-selectin cDNA-transfected lymphoblastoid cells. Coumermycin- induced L-selectin dimerization resulted in an approximately fourfold increase in binding of phosphomanan monoester core complex (PPME), a natural mimic of an L-selectin ligand, comparable to that observed after leukocyte activation. Moreover, L-selectin dimerization significantly increased (by ∼700%) the number of lymphocytes rolling on vascular endothelium under a broad range of physiological shear stresses, and significantly slowed their rolling velocities. Therefore, L-selectin dimerization may explain the rapid increase in ligand binding activity that occurs after leukocyte activation and may directly influence leukocyte migration to peripheral lymphoid tissues or to sites of inflammation. Inducible oligomerization may also be a common mechanism for rapidly upregulating the adhesive or ligand-binding function of other cell-surface receptors.
Skip Nav Destination
Article navigation
5 October 1998
Brief Definitive Report|
October 05 1998
Regulation of L-Selectin–mediated Rolling through Receptor Dimerization
Xuan Li,
Xuan Li
From the *Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710; and ‡Merck Co., Inc., Rahway, New Jersey 07065
Search for other works by this author on:
Douglas A. Steeber,
Douglas A. Steeber
From the *Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710; and ‡Merck Co., Inc., Rahway, New Jersey 07065
Search for other works by this author on:
Mimi L.K. Tang,
Mimi L.K. Tang
From the *Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710; and ‡Merck Co., Inc., Rahway, New Jersey 07065
Search for other works by this author on:
Michael A. Farrar,
Michael A. Farrar
From the *Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710; and ‡Merck Co., Inc., Rahway, New Jersey 07065
Search for other works by this author on:
Roger M. Perlmutter,
Roger M. Perlmutter
From the *Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710; and ‡Merck Co., Inc., Rahway, New Jersey 07065
Search for other works by this author on:
Thomas F. Tedder
Thomas F. Tedder
From the *Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710; and ‡Merck Co., Inc., Rahway, New Jersey 07065
Search for other works by this author on:
Xuan Li
From the *Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710; and ‡Merck Co., Inc., Rahway, New Jersey 07065
Douglas A. Steeber
From the *Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710; and ‡Merck Co., Inc., Rahway, New Jersey 07065
Mimi L.K. Tang
From the *Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710; and ‡Merck Co., Inc., Rahway, New Jersey 07065
Michael A. Farrar
From the *Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710; and ‡Merck Co., Inc., Rahway, New Jersey 07065
Roger M. Perlmutter
From the *Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710; and ‡Merck Co., Inc., Rahway, New Jersey 07065
Thomas F. Tedder
From the *Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710; and ‡Merck Co., Inc., Rahway, New Jersey 07065
Address correspondence to Thomas Tedder, Box 3010, Department of Immunology, Rm. 353 Jones Bldg., Research Dr., Duke University Medical Center, Durham, NC 27710. Phone: 919-684-3578; Fax: 919-684-8982; E-mail: [email protected]
Received:
June 15 1998
Revision Received:
July 23 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 188 (7): 1385–1390.
Article history
Received:
June 15 1998
Revision Received:
July 23 1998
Citation
Xuan Li, Douglas A. Steeber, Mimi L.K. Tang, Michael A. Farrar, Roger M. Perlmutter, Thomas F. Tedder; Regulation of L-Selectin–mediated Rolling through Receptor Dimerization . J Exp Med 5 October 1998; 188 (7): 1385–1390. doi: https://doi.org/10.1084/jem.188.7.1385
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement